Scinai
Highly Engaged Employees
Highly Engaged EmployeesChemicals & Related Products · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Kiryat Hadassah Building 1 Jerusalem Bio...Phone Number
+97289293040Website
www.scinai.comRevenue
<$5 MillionStock Symbol
SCNIIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Scinai
Scinai Immunotherapeutics Ltd. is a Jerusalem, Israel-based biopharmaceutical company listed on Nasdaq under SCNI. It develops nanosized VHH antibodies (NanoAbs) for inflammatory and immunological diseases, including psoriasis, along with PC111 for autoimmune skin conditions such as pemphigus. The company also provides process development and cGMP manufacturing services through Scinai Biopharma Services.Explore more
Scinai Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scinai your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Scinai recently announced quarterly report
Product Launch: Get notified when Scinai launches new products
Funding: Get notified immidiatlly once Scinai has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Scinai is spiking on competitors!
Click to see if Scinai had a recent Job posting/layoffs
Scinai, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Scinai has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Scinai
Recommended Actions
Find VP level buyers at Scinai
Find 3 more new buyers
Company Profile Activity
Activity Insights
Scinai is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Scinai is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Scinai.
Scinai financials insights
Gather financial insights about Scinai, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$2.6M
Scinai Tech Stack
A closer look at the technologies used by Scinai
Most Recent Scoops
Earnings
Earnings, Finance
Funding
Funding
Earnings
Earnings, Finance
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Earnings
Earnings, Finance
Scinai News & Media
Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and ...
/PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company combining innovative immunology...Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business
Following the conclusion of the PinCell option and license arrangements, Scinai concentrates resources on its NanoAb platform and CDMO commercial execution, without taking on additional PC111 funding commitments JERUSALEM, Sept. 8, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd....Scinai Immunotherapeutics Ltd. (SCNI) Q2 2026 Earnings Call Transcript
Scinai Immunotherapeutics Ltd. (SCNI) Q2 2026 Earnings Call August 26, 2026 11:00 AM EDTCompany ParticipantsAmir Reichman - CEO & DirectorConference...Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum
Investor webinar scheduled for August 26, 2026 at 11:00 a.m. EDT JERUSALEM, Aug. 24, 2026 /PRNewswire/ – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company combining innovative therapeutic development with a revenue-generating contract...
Read more news
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scinai
Sign Up For FreeTo access detailed company insights
Scinai Immunotherapeutics Ltd. is a Jerusalem, Israel-based biopharmaceutical company listed on Nasdaq under SCNI. It develops nanosized VHH antibodies (NanoAbs) for inflammatory and immunological diseases, including psoriasis, along with PC111 for autoimmune skin conditions such as pemphigus. The company also provides process development and cGMP... Read More
